Brogden Danielle R L, Khoo Christopher C, Kontovounisios Christos, Pellino Gianluca, Chong Irene, Tait Diana, Warren Oliver J, Bower Mark, Tekkis Paris, Mills Sarah C
Chelsea and Westminster Hospitals NHS Foundation Trust, London, UK.
Imperial College London, London, UK.
Discov Oncol. 2021;12(1):3. doi: 10.1007/s12672-021-00397-7. Epub 2021 Feb 11.
Anal Squamous Cell Carcinoma (ASCC) is a rare cancer that has a rapidly increasing incidence in areas with highly developed economies. ASCC is strongly associated with HIV and there appears to be increasing numbers of younger male persons living with HIV (PLWH) diagnosed with ASCC. This is a retrospective cohort study of HIV positive and HIV negative patients diagnosed with primary ASCC between January 2000 and January 2020 in a demographic group with high prevalence rates of HIV. One Hundred and seventy six patients were included, and clinical data was retrieved from multiple, prospective databases. A clinical subgroup was identified in this cohort of younger HIV positive males who were more likely to have had a prior diagnosis of Anal Intraepithelial Neoplasia (AIN). Gender and HIV status had no effect on staging or disease-free survival. PLWH were more likely to develop a recurrence (p < 0.000) but had a longer time to recurrence than HIV negative patients, however this was not statistically significant (46.1 months vs. 17.5 months; p = 0.077). Patients known to have a previous diagnosis of AIN were more likely to have earlier staging and local tumour excision. Five-year Disease-Free Survival was associated with tumour size and the absence of nodal or metastatic disease (p < 0.000).
肛管鳞状细胞癌(ASCC)是一种罕见癌症,在经济高度发达地区其发病率正迅速上升。ASCC与艾滋病病毒(HIV)密切相关,而且被诊断患有ASCC的感染HIV的年轻男性人数似乎在不断增加。这是一项对2000年1月至2020年1月期间在一个HIV高流行率人群中被诊断患有原发性ASCC的HIV阳性和HIV阴性患者的回顾性队列研究。纳入了176名患者,并从多个前瞻性数据库中检索了临床数据。在这个队列中确定了一个临床亚组,即更有可能先前被诊断患有肛管上皮内瘤变(AIN)的年轻HIV阳性男性。性别和HIV状态对分期或无病生存期没有影响。感染HIV的患者更有可能出现复发(p < 0.000),但与未感染HIV的患者相比,复发时间更长,不过这在统计学上并不显著(46.1个月对17.5个月;p = 0.077)。已知先前诊断患有AIN的患者更有可能处于早期分期并接受局部肿瘤切除。五年无病生存期与肿瘤大小以及无淋巴结或转移性疾病相关(p < 0.000)。